Sponsor:
Andarix Pharmaceuticals
Code:
NCT00100256
Conditions
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Neoplasm Recurrence, Local
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Rhenium (Re 188 P2045, BAY86-5284)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations